Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Hepatitis

  Free Subscription


21.04.2020

2 Am J Gastroenterol
1 Blood
2 BMC Gastroenterol
1 Clin Infect Dis
1 Dig Dis Sci
1 Dtsch Med Wochenschr
2 Eur J Gastroenterol Hepatol
1 Gastroenterol Hepatol
3 Gastroenterology
1 Gut
1 Hepatology
1 J Hepatol
1 J Med Virol
4 J Viral Hepat
3 PLoS One
1 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Gastroenterol

  1. WANDER P, Epstein M, Bernstein D
    COVID-19 Presenting as Acute Hepatitis.
    Am J Gastroenterol. 2020 Apr 15. doi: 10.14309/ajg.0000000000000660.
    PubMed        

  2. DIAO YK, Jia HD, Huang DS, Zhang CW, et al
    Is Serum Transferrin an Independent Predictor of Mortality in Severe Alcoholic Hepatitis?
    Am J Gastroenterol. 2020 Apr 15. doi: 10.14309/ajg.0000000000000601.
    PubMed        


    Blood

  3. CAO W, Wei J, Wang N, Xu H, et al
    Entecavir Prophylaxis for Hepatitis B Virus Reactivation in Patients with CAR T-cell Therapy.
    Blood. 2020 Apr 14. pii: 454385. doi: 10.1182/blood.2020004907.
    PubMed        


    BMC Gastroenterol

  4. LEE HW, Lee JI, Kim S, Kim S, et al
    Cumulative incidence of hepatocellular carcinoma and hepatitis B surface antigen Seroclearance after Nucleos(t) ide analogue-induced hepatitis B e antigen Seroclearance.
    BMC Gastroenterol. 2020;20:113.
    PubMed         Abstract available

  5. LI Q, Lu Q, Zhu MQ, Huang C, et al
    Lower level of complement component C3 and C3a in the plasma means poor outcome in the patients with hepatitis B virus related acute-on-chronic liver failure.
    BMC Gastroenterol. 2020;20:106.
    PubMed         Abstract available


    Clin Infect Dis

  6. CHAILLON A, Wynn A, Kushner T, Reau N, et al
    Cost-Effectiveness of Antenatal Rescreening Among Pregnant Women for Hepatitis C in the United States.
    Clin Infect Dis. 2020 Apr 13. pii: 5819607. doi: 10.1093.
    PubMed         Abstract available


    Dig Dis Sci

  7. OUZAN D, Larrey D, Guyader D, Remy AJ, et al
    Evolution of Hepatitis C Virus Treatment During the Era of Sofosbuvir-Based Therapies: A Real-World Experience in France.
    Dig Dis Sci. 2020 Apr 18. pii: 10.1007/s10620-020-06234.
    PubMed         Abstract available


    Dtsch Med Wochenschr

  8. BERT F, Rossol S
    [Acute exacerbation of reactivated chronic hepatitis-b after stopping antiviral medication followed by loss of HBsAg].
    Dtsch Med Wochenschr. 2020;145:552-554.
    PubMed         Abstract available


    Eur J Gastroenterol Hepatol

  9. CHEN D, Wen S, Wu Z, Gu Y, et al
    Association between effective hepatic blood flow and the severity and prognosis of hepatitis B virus-related acute on chronic liver failure.
    Eur J Gastroenterol Hepatol. 2020 Apr 10. doi: 10.1097/MEG.0000000000001721.
    PubMed         Abstract available

  10. KUMADA T, Toyoda H, Tada T, Yasuda S, et al
    Comparison of the impact of tenofovir alafenamide and entecavir on declines of hepatitis B surface antigen levels.
    Eur J Gastroenterol Hepatol. 2020 Apr 10. doi: 10.1097/MEG.0000000000001733.
    PubMed         Abstract available


    Gastroenterol Hepatol

  11. GUZMAN RAMOS MI, Manzano-Garcia M, Robustillo-Cortes MLA, Pineda JA, et al
    Effect on the adherence to concomitant medications after initiation of treatment with direct-acting antiviral agents against hepatitis C virus.
    Gastroenterol Hepatol. 2020 Apr 9. pii: S0210-5705(20)30071.
    PubMed         Abstract available


    Gastroenterology

  12. SALINAS E, Grakoui A
    Monkey in the Middle: Dynamics of Interspecies Antibody Responses.
    Gastroenterology. 2020;158:820-822.
    PubMed        

  13. LE BERT N, Gill US, Hong M, Kunasegaran K, et al
    Effects of Hepatitis B Surface Antigen on Virus-specific and Global T Cells in Patients With Chronic HBV infection.
    Gastroenterology. 2020 Apr 14. pii: S0016-5085(20)30492.
    PubMed         Abstract available

  14. CARVAO J, Pereira VM, Jasmins L
    A case of unexplained cutaneous lesions, cholestatic hepatitis and non-cirrhotic portal hypertension in a female patient.
    Gastroenterology. 2020 Apr 16. pii: S0016-5085(20)30494.
    PubMed        


    Gut

  15. YOUNOSSI ZM, Stepanova M, Younossi Y, Golabi P, et al
    Epidemiology of chronic liver diseases in the USA in the past three decades.
    Gut. 2020;69:564-568.
    PubMed         Abstract available


    Hepatology

  16. MELE D, Oliviero B, Mantovani S, Ludovisi S, et al
    Adaptive Natural Killer Cell Functional Recovery in Hepatitis C Virus Cured Patients.
    Hepatology. 2020 Apr 13. doi: 10.1002/hep.31273.
    PubMed         Abstract available


    J Hepatol

  17. KINAST V, Plociennikowska A, Anggakusuma, Bracht T, et al
    C19orf66 is an interferon-induced inhibitor of HCV replication that restricts formation of the viral replication organelle.
    J Hepatol. 2020 Apr 12. pii: S0168-8278(20)30209.
    PubMed         Abstract available


    J Med Virol

  18. KODANI M, Poe A, Drobeniuc J, Hayden T, et al
    Determination of potential biotin interference on accuracy of results of serologic assays for various viral hepatitis markers.
    J Med Virol. 2020 Apr 14. doi: 10.1002/jmv.25880.
    PubMed         Abstract available


    J Viral Hepat

  19. HUANG X, Young KH, Guo W, Wang Y, et al
    Identification of Hepatitis B virus etiologic antigens, HBx and Pre-S2, in Diffuse Large B-cell Lymphoma.
    J Viral Hepat. 2020 Apr 13. doi: 10.1111/jvh.13301.
    PubMed         Abstract available

  20. AMOUGOU-ATSAMA M, Atangana PJA, Noah Noah D, Fewou Moundipa P, et al
    The role of hepatitis C virus genotypes and core mutations inhepatocellular carcinomain Cameroon.
    J Viral Hepat. 2020 Apr 16. doi: 10.1111/jvh.13303.
    PubMed         Abstract available

  21. LI YR, Chen WC, Tsai WL, Cheng JS, et al
    Severe acute exacerbation of HCV infection in cancer patients who undergo chemotherapy without anti-viral prophylaxis.
    J Viral Hepat. 2020 Apr 16. doi: 10.1111/jvh.13302.
    PubMed         Abstract available

  22. LEE J, Park JY, Yang SJ, Lee JY, et al
    Renal safety of tenofovir disoproxil fumarate and entecavir with hepatitis B immunoglobulin in liver transplant patients.
    J Viral Hepat. 2020 Apr 17. doi: 10.1111/jvh.13291.
    PubMed         Abstract available


    PLoS One

  23. PRINSENBERG T, Rebers S, Boyd A, Zuure F, et al
    Dried blood spot self-sampling at home is a feasible technique for hepatitis C RNA detection.
    PLoS One. 2020;15:e0231385.
    PubMed         Abstract available

  24. CHIU SM, Tsai MC, Lin CY, Chen CH, et al
    Serial changes of renal function after directly acting antivirals treatment for chronic hepatitis C: A 1-year follow-up study after treatment.
    PLoS One. 2020;15:e0231102.
    PubMed         Abstract available

  25. KRACHT PAM, Arends JE, Hoepelman AIM, Vervoort SCJM, et al
    The balancing perspective of hard-to-reach hepatitis C patients who were lost to follow-up: A qualitative study.
    PLoS One. 2020;15:e0230756.
    PubMed         Abstract available


    Vaccine

  26. JOE CCD, Chatterjee S, Lovrecz G, Adams TE, et al
    Glycoengineered hepatitis B virus-like particles with enhanced immunogenicity.
    Vaccine. 2020 Apr 10. pii: S0264-410X(20)30350.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: